Survival of patients with newly diagnosed high-grade myeloid neoplasms who do not meet standard trial eligibility

Few patients with cancer, including those with acute myeloid leukemia and high-grade myeloid neoplasms, participate in clinical trials. Broadening standard eligibility criteria may increase clinical trial participation. In this retrospective single-center analysis, we identified 442 consecutive newl...

Descripción completa

Detalles Bibliográficos
Autores principales: Percival, Mary-Elizabeth M., Othus, Megan, Mirahsani, Sarah, Gardner, Kelda M., Shaw, Carole, Halpern, Anna B., Becker, Pamela S., Hendrie, Paul C., Sorror, Mohamed L., Walter, Roland B., Estey1, Elihu H.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Fondazione Ferrata Storti 2020
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8327712/
https://www.ncbi.nlm.nih.gov/pubmed/32646891
http://dx.doi.org/10.3324/haematol.2020.254938

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8327712/
https://www.ncbi.nlm.nih.gov/pubmed/32646891
http://dx.doi.org/10.3324/haematol.2020.254938

Ejemplares similares